This work serves to underline the importance of NRF2 in C9orf72-related ALS and as a proof of concept to emphasize the importance of its activation as a potential therapeutic target, since Arg-DPRs toxicity can be prevented by NRF2 overexpression. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.